Neff R Matthew 4/A
4/A · BIOANALYTICAL SYSTEMS INC · Filed Jan 12, 2021
Insider Transaction Report
Form 4/AAmended
Neff R Matthew
Director
Transactions
- Purchase
Common Shares
[F1]2020-02-20$4.60/sh+9,458$43,507→ 31,583 total
Footnotes (1)
- [F1]The reporting person filed this amendment to correct the amount of securities identified as beneficially owned following the reported transaction.
Signature
/s/ Beth Taylor, attorney-in-fact for R. Matthew Neff|2021-01-12